Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
HRD + BRCA wild-type
i
Other names:
HRD, Homologous Recombination Deficiency, BRCA, Breast cancer, early onset
Associations
(6)
News
Trials
A2 | Sensitive
C3 | Sensitive
A2 | Resistant
C3 | Resistant
Show legend
Drug categories
Tyrosine Kinase Inhibitors
PARP Inhibitors
Chemotherapy
DNA
Cancel
Ovarian Cancer
Triple Negative Breast Cancer
bevacizumab
A2
HRD + BRCA wild-type
|
Ovarian Cancer
|
bevacizumab
bevacizumab + olaparib
A2
HRD + BRCA wild-type
|
Ovarian Cancer
|
bevacizumab + olaparib
niraparib
A2
HRD + BRCA wild-type
|
Ovarian Cancer
|
niraparib
D19466
C3
HRD + BRCA wild-type
|
Triple Negative Breast Cancer
|
D19466
carboplatin
C3
HRD + BRCA wild-type
|
Triple Negative Breast Cancer
|
carboplatin
cisplatin
C3
HRD + BRCA wild-type
|
Triple Negative Breast Cancer
|
cisplatin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
